HARVARD MANAGEMENT CO INC - Q3 2023 holdings

$886 Million is the total value of HARVARD MANAGEMENT CO INC's 22 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 39.4% .

 Value Shares↓ Weighting
FB SellMeta Platforms Inccl a$287,753
-11.7%
958,505
-15.6%
32.48%
+1.5%
GOOGL SellAlphabet Inccap stk cl a$227,549
-21.2%
1,738,875
-27.9%
25.69%
-9.3%
SGMS  Light & Wonder Inc$191,062
+3.7%
2,678,5710.0%21.57%
+19.3%
 Grab Holdings Limitedclass a ord$46,149
+3.2%
13,036,4820.0%5.21%
+18.7%
NVDA  Nvidia Corporation$21,875
+2.8%
50,2890.0%2.47%
+18.2%
TSM  Taiwan Semiconductor Mfg Ltdsponsored ads$17,584
-13.9%
202,3470.0%1.98%
-0.9%
AMD  Advanced Micro Devices Inc$17,213
-9.7%
167,4060.0%1.94%
+3.8%
ASML  ASML Holding N V$16,199
-18.8%
27,5190.0%1.83%
-6.5%
NewMaplebear, Inc$15,434519,838
+100.0%
1.74%
PCTTW  Purecycle Technologies Inc*w exp 03/17/202$14,015
-47.5%
2,498,1700.0%1.58%
-39.6%
 Tango Therapeutics Inc$7,976
+239.1%
708,3850.0%0.90%
+289.6%
TXG Sell10X Genomics Inc$7,013
-32.5%
170,000
-8.7%
0.79%
-22.4%
 Rocket Lab Usa Inc$4,380
-27.0%
1,000,0000.0%0.49%
-16.1%
CFLT  Confluent Inc$3,861
-16.1%
130,3830.0%0.44%
-3.5%
 Tenaya Therapeutics Inc$1,717
-56.6%
673,2700.0%0.19%
-50.0%
 Vigil Neuroscience Inc$1,560
-42.7%
289,4600.0%0.18%
-34.1%
PCT  Purecycle Technologies Inc$1,186
-62.2%
714,2850.0%0.13%
-56.5%
 Nauticus Robotics Inc.$885
-16.5%
500,0000.0%0.10%
-3.8%
 Xilio Therapeutics Inc$878
-19.4%
416,0590.0%0.10%
-7.5%
SANA SellSana Biotechnology Inc$837
-70.0%
216,376
-53.8%
0.09%
-65.7%
 Surrozen Inc$405
-11.0%
826,8520.0%0.05%
+2.2%
MCRB  Seres Therapeutics Inc$314
-50.3%
131,8470.0%0.04%
-43.5%
MGTA ExitMagenta Therapeutics Inc$0-332,610
-100.0%
-0.02%
ExitDisc Medicine Inc$0-8,452
-100.0%
-0.04%
ExitPardes Biosciences Inc$0-400,000
-100.0%
-0.07%
PRAX ExitPraxis Precision Medicines Inc$0-692,617
-100.0%
-0.08%
FULC ExitFulcrum Therapeutics Inc$0-341,972
-100.0%
-0.11%
DBTX ExitDecibel Therapeutics Inc$0-326,029
-100.0%
-0.12%
KNTE ExitKinnate Biopharma Inc$0-462,418
-100.0%
-0.14%
GBIO ExitGeneration Bio Co$0-510,354
-100.0%
-0.28%
PACB ExitPacific Biosciences Calif Inc$0-233,186
-100.0%
-0.30%
NRIX ExitNurix Therapeutics Inc$0-314,762
-100.0%
-0.31%
RXRX ExitRecursion Pharmaceuticals Incl a$0-882,129
-100.0%
-0.65%
ExitEQRX Inc$0-3,853,367
-100.0%
-0.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (885845003.0 != 885845.0)

Export HARVARD MANAGEMENT CO INC's holdings